STAT Plus: Novartis sells bonds tied to expanding access to medicines in poor countries
In a first-of-its-kind move by a large drug maker, Novartis (NVS) raised approximately $2.1 billion last week by selling bonds that are tied directly to...
Tag : Novartis
STAT Plus: Novartis and Roche are fined $528 million for anti-competitive practices in France
France’s anti-trust regulator fined Roche (RHHBY) and Novartis (NVS) a combined $528 million for conspiring to boost sales of a pricey treatment for a serious...
STAT Plus: Otsuka approved to buy bankrupt smart-pill maker Proteus’ assets, overcoming opposition from Novartis
The Japanese drug maker Otsuka has been approved to purchase the assets of bankrupt smart pill maker Proteus Digital Health for $15 million — capping...
Hypertrophic Cardiomyopathy Pipeline 2020 Featuring Algomedix, Celltrion, MyoKardia, Novartis and 4 Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Hypertrophic Cardiomyopathy Pipeline Research Monitor, 2020 – Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook” report has been added to ResearchAndMarkets.com’s...
STAT Plus: Novartis to provide drugs for Covid-19 patients to poor countries at no cost, but fails to disclose pricing
As companies face pressure to ensure access to medicines during the pandemic, Novartis (NVS) plans to sell more than a dozen older drugs at cost...
Novartis, Propeller Health co-package new asthma treatment
The co-packaged product, which will be launched in Europe this year, combines Propeller’s sensor tech and Novartis’ new medication. Source link...
STAT Plus: Pharmalittle: Trump officials maintain Covid-19 vaccine won’t be influenced by politics; Novartis pays $678 million to settle kickback charges
And so, another working week will soon come to an end. Not a moment too soon, yes? For those who think this may sound premature,...
European Antibiotics Market Assessment and Forecast to 2027 with Profiles of GlaxoSmithKline, Sanofi, Novartis, Bayer and Pfizer – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Antibiotics Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Drug Class; Action Mechanism; and Country” report has been added...
Novartis agrees to $642mn US settlement over kickbacks
Swiss pharmaceutical giant Novartis has agreed to pay more than $642 million to settle a lawsuit which accused it of paying kickbacks to doctors, among...
STAT Plus: Novartis pays $678 million to settle a long-running case over alleged kickbacks to doctors
After seven years of sparring, Novartis (NVS) has agreed to pay $678 million to settle a lawsuit in which the federal government alleged the drug...
STAT Plus: Novartis to pay $345 million to U.S. authorities for bribing doctors in different countries
Novartis (NVS) agreed to pay more than $345 million to resolve criminal charges brought by federal authorities of using various former and existing subsidiaries to...
Novartis to pay $336 mn in US settlements on bribes
Novartis agreed to pay around $336 million to settle US charges connected to bribery schemes aimed at increasing sales of its pharmaceutical products, US authorities...
Swiss giant Novartis halts COVID-19 hydroxychloroquine study
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for...
World Sickle Cell Day 2020: Novartis Takes Further Steps to Make Sickle Cell Disease a Healthcare Priority in Europe
BASEL, Switzerland–(BUSINESS WIRE)–STRICTLY FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY Many patients with SCD only live into their 40s and endure unpredictable pain crises...
STAT Plus: Pharmalittle: Novartis to test hydroxycholoroquine in Covid-19; malaria drug failed to protect lupus patients from coronavirus
Good morning, everyone, and welcome to another working week. We hope the weekend offered something of a respite, such as it is. In any event,...
Novartis steps up to study of hydroxychloroquine in Covid-19
The drug giant Novartis said Monday it would conduct a 450-person study to determine if hydroxychloroquine, the malaria drug touted by many pundits and President...
STAT Plus: Pharmalittle: Novartis scraps generic sale to Aurobindo; another small study suggests old malaria drug works
Rise and shine, everyone, another busy day is on the way. How could it be otherwise? Despite empty streets, the usual buzz of activity is...
STAT Plus: FDA closes review of Novartis data integrity scandal without punishing the drug maker
An embarrassing scandal that Novartis (NVS) endured over data integrity has quietly come to a close, with the Food and Drug Administration instructing the drug...
STAT Plus: Pharmalittle: A TB vaccine is tested against the coronavirus; FDA doesn’t punish Novartis over data integrity scandal
Hello, everyone, and how are you coping this morning? We are doing just fine, thank you, as we continue to adjust to this new world....
STAT Plus: Novartis generic unit to pay $195 million to settle price fixing charges
In the latest fallout from a federal probe into generic drug price fixing, the Sandoz unit of Novartis (NVS) agreed to pay $195 million to...